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Eye-derived growth factor (EDGF) has been found in sev-
eral ocular tissues and shown to be able to stimulate the in 
vitro proli fe ration of cell s from various tissues and orga-
nisms. It had already been shown that EDGF differs bio-
chemically and biologically from other growth fac tors such 
as epidermal growth factor (EGF) and fib ro blas t growth 
factor in that it is the only one that can stimulate the in 
vitro growth of human adult keratinocytes. Moreover EDGF 
stimulates rflepithelializa tion and neovascularization. In this 
paper we report data concerning the effect on the rate of 
epidermal wound healing in guinea pigs of different ex-
tracts obtained fron1. adult bovine retina. 
O ur results show that EDGF can significantly increase 
the rate of reepithelializa tion w hen epidermis is detached 
from dermis and removed after induction of a blister. The 
M ost peptide g rowth fac to rs have been iso lated and characterized accordin g to thei r capability to s timulate cell prolifera ti o n in tissue cu lture . In v ivo , g rowth fac to rs are tho ug ht to play an im-po rtan t role during embryogenesis, tissue ho-
m eostasis, and cell regeneratio n . T here is , however, no clea r un-
ders tanding of the ph ysiologic rol e o f g rowth fa cto rs and o nly 
few studies o n the activ ity o f these m aterials in v ivo have been 
repo rted . 
O ne o f the po tential interes ts in g rowth fac to rs is their use as 
p harm acologic agents to accelerate wound healing. G reat is the 
need fo r rapid healing in the t rea tm ent of severe skin burns, g rafts, 
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Abbreviations: 
BEL: bovine epithelial ce lls 
CMC: carboxymethyl cellu lose 
ECGF: endo thelial cell g rowth factor 
EDG F: eye-derived growth facto r 
EGF: epidermal growth fac tor 
FGF: fi broblas t growth facto r 
KGF: keratinocytc growth fac tor 
MGF: mesoderm al growth factor 
PAS: periodic acid Schiff 
PBS: phosphate-buffe red saline 
SU: stimulation unit (s) 
TGF: transforming growth fac tor 
doses used were co mparable to the ones used to o btain 
maximal increase of cell proliferation in vitro . H owever 
no attempt was made to furth er in ves ti ga te the mechanism 
accountin g fo r the observed wound healing. At 24 h , COI1-
trol wounds maintained under occlusive dressing had only 
about 50% of their surface covered w ith cells as opposed 
to EDGF-treated wounds which w ere covered up to about 
80% (p = 0.05) . On the o ther han.d , EGF does no t in crease 
the rate of wound healing in this model even at lOOO-fold 
higher doses than those used in in vitro bioassa ys. Altho ugh 
EDGF is still not purified to homogeneity and another 10-
to 100- fold purifica tion mi ght be necessary to achieve hom-
ogeneity, our results sugges t that ED GF may fl\1d thera-
peutic applica tions as a potent in vivo epidermal wound 
healing agent. } In vest D ermatol 87:76- 80, 1986 
trauma, eschars, and ulcers o f all ori g in s and all tissues, and yet 
th ere is no suitable pharmaceuti ca l agen t avail able. 
A sig nificant effec t of several g rowth fac to rs including epider-
mal g rowth fac tor (EG F) , fibrobl as t g ro wth facto r (FGF), and 
m esod ermal growth fac tor (M G F) o n the rate of wound healing 
of corn eal epithelium ulcers has been repo rted b y severa l grou ps 
[1-4] . H o w ever wh en tes ted o n adult human keratinocytes in 
ti ssue culture, these grow th facto rs were fo und to be unable to 
indu ce cell p roliferatio n [5] . M o use EG F was also fo und ineffec-
ti ve in stimulating epide rmal wo und healin g in blis te r w o u nd 
induced o n hum ans [6] . 
A recently isolated fa mily o f poly peptide t rans fo rmin g growth 
facto rs (T GF) was sho wn to accelera te wound hea lin g w hen in-
j ected alo ne o r w ith EG F in a w ire m esh wo und cha mber inserted 
subcutaneously [7] . T he woun d hea lin g was assessed b y d eter-
mining the number of fi b ro blas ts and the am o unt o f collagen in 
the chamber. 
H owever it was no t repo rted that ke rat in ocy tes were s timulated 
o r that they were eventually present afte r healin g. M o re recentl y, 
human EG F pro du ced thro ug h reco mbin ant D NA techniques ha 
been shown to in crease the rate o f epitheli aliza tio n in split-thick-
ness wounds in miniature pigs in vi vo. H owever the con centra- I 
tio n used w as 1000- fo ld g rea ter than the o ne need ed for m axi m al 
s timulatio n in ti ssue culture [8]. 
W e previo usly repo r ted that adult bovine retin a con ta ins a poly-
peptide, eye-derived growth fac to r (EDG F) , w hi ch ca n s timul ate 
th e in vit ro prolifera tio n of cell s fro m va rio us orig ins [9, 10] . Thi 
g ro wth fac to r has been purified o ver 10,000- fo ld and character-
ized . It is a polypeptide o f M , 17,500 and p i of 4 .5 w hich can 
indu ce target cells to pro li fe rate in vit ro a t d oses of6 ng/ml [11]. 
E D G F was also fo und in o ther ocu lar ti ssues and was shown to 
be different fro m EG F and FG F b y bo th its bioche mical and 
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Figure 1. Epidermal regeneration vs time in untreated wounds. Mean 
va lue of the hea ling ratio ± confidence interval. 
biologic properties [9, 12]. O ne o f the maj o r di fferences with re-
ga rd to the biologic properties o f these g rowth facto rs is the abilit y 
o f ED G F to stimulate the in vitro proliferation of adult human 
keratin ocytes without any need fo r a feeder layer [1 3]. This ability 
was no t detected for FG F [5] and was observed with EG F onl y 
o n newborn keratinocytes [14] . C rude extracts o f hypothalamus 
were al so reported to stimulate adult human keratin ocytes to 
proliferate in vitro [15] and this mitogenic acti vity is supported 
by a dialyzable and heat stable molecule of M, 1700 acid nam ed 
keratinocy te g rowth fa cto r [1 6], w hich is clearly different from 
endo thelial cell growth fac tor (ECGF) [17]. H owever no in vivo 
effect o f this g rowth facto r has yet been reported. 
Since we had shown th at ED GF is also able to stimulate co rnea l 
epithelial cell s to proliferate in vivo [18] and th at in that res pect 
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it is a wound healing agent fo r co rnea l ulcers as effi cient as EGF 
and FGF [3], it w as of interest to learn w hether E D GF can also 
stimulate the reepithelializa tion of the skin in vivo. 
MATEHIALS AND METHO DS 
Growth Factor Preparations Eye-deri ved growth facto r w as 
prepared as described [11] . Briefl y, adult bov ine retin a collected 
fro m freshl y slaughtered animals w as homogenized in phos phate-
buffered saline (PB S) and centrifuged. T he supernatant was sub-
j ected to ammonium sulfate fractionati on and the ac tive fraction 
w as found to be between 20-60% . This frac tion w as di alyzed 
against 0. 1 N acetic acid . The precipitate was removed and the 
supern at:lIlt w as dialyzed against PBS . This fra ction was ca lled 
the aceti c acid-purified EDGF. 
"Further purifi ca ti on was obtained by elution with 2. 15 M N aCI 
o f the material retained on cibacron blue. 
In these experiments either aceti c acid- o r cibacron blue-purifi ed 
EDG F w as used. The stimulation unit (SU) was measured as 
previously described [1 9]. Briefl y, dose-response curves o f in-
co rporation of tritiated th ymidine ill bovine epithelial lens cells 
vs E D GF concentration were obtained and the SU was defin ed 
as th e amount o f protein added to 1 ml of culture medium that 
induces half the maximum th ymidine incorpo rati on in bovine 
epithelial (BEL) cells. Samples w ere in PBS. ED G F preparations 
at the acetic acid purifi cati on step with a SU at 400 ng/ml and at 
the cibacron blue step at 30 ng/ml w ere used. 
Epidermal g rowth factor was obtained from Collabo rative He-
sea rch (culture g rade) w ith a SU measured on rat 3T 3 cells o f 15 
ng/ml. Gelifica tion of g row th fa ctors for topical application was 
achieved, befo re the experiment, using 2.5% ca rboxymethyl cel-
lu lose (C M C) . Volumes of 0.1 ml o f the gelified solution w ith 
SU as indica ted in the results were applied on the wound as 
described below. Controls containing only geJifi ed PBS were 
used. 
Wounding Methods Youn g m ale H artley guinea pigs (400 g) 
were depil ated 72 h prio r to the expe rim ent. The wounds were 
obta ined by 2 suction cups placed on the depil ated abdominal 
skin o f each an estheti zed animal. The cups used were similar to 
th ose described by K iistala and Mustakallio [20], w ith an inside 
diam eter of 8 111m , and were m aintained at a press ure of1 20 111m 
H g below atm os pheri c pressure for 2 h. This procedure allowed 
the separation of epidermis from the dermi s. The roof o f th e 
resulting blister w as removed leaving a pure epidermal w ound 
as described by Ortonne et al [21]. The integrity o f the basement 
membrane was controlled by photon microscopy after staining 
the histologic secti ons with peri odic acid Schiff (PAS) as well as 
by electron microscopy. The initial surface o f this w ound w as 
recorded by tracing its outline onto a g lass microscope slide. The 
gelified solution of ED GF was applied on one of the wound s, 
th e o ther received the placebo gel. Therea fter the wounds were 
Table I. Effect of Growth Facto r on Wound H ealing 
Hours 
Average of the Healing Ratio" 
Number 
Average of the Healing Ratio" 
Number 
After Control EDGF in Stimulation of Control EDGF in Stimulation of 
Wounding Exp. (CMC Gel) CMC Gel Units' Animals l (Water) Water Units' Animals l 
0 1. 00 1. 00 16 1. 00 1.00 12 
18 0.50 ± 0.06 0.32 ± 0.1 5 5 16 < 0.1 
24 1 st 0.52 ± 0.10 0.23 ± 0.06 5 16 < 0.05 0.52 ± 0.08 0. 28 ± 0.07 10 12 < 0.02 
2nd 0.47 ± 0. 10 0.20 ± 0.07 ..s 16 < 0. 05 
3rd 0.40 ± 0.09 0. 14 ± 0.03 10 16 < 0.02 
48 0.06 ± 0.01 0. 02 ± 0.01 12 NS 
Di fferent res ults ob tained 24 h after wo undin g 3re due to individual variation of animals and different doses of eye-deri ved growth facto r (EDGF) used. ± = SEM; 
NS = not signifi ca nt. 
:csl:cIr:cG~cc~of:ct:ch~e~w~o:cu~n~d~x~h~o~ur~s~a~u~er~'~v~ol=":c,d:cil~l g 
<l'J-Icaling rati o = ~ 
ini tial surf.1ce of the wound 
bVa lues based on Student Fisher T est. 
{$ timui:Hio n unit (S U ) is defined as th e amo unt o f growth facto r added to I ml o f culture medium w hich can induce 50% maxim al incorpo ratio n o f F'Hlth ymi dinc in 
targer cells. Ten SU correspond to 300 ng (17 I'M) of the most purified preparations of EDGF (M, = 17.500). 
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covered with a polyethylene fdm taped to the skin, 1 cm from 
the edge of the wound. Eighteen or twenty-four hours after 
wounding, the an imals were sacrificed and 2 skin biopsies (3 x 
3 cm) including the wounds as well as adj acent non wounded areas 
of skin were made for each animal and incubated for 3 h in 2 N 
N aBr at 37°C. The epidermis was then separa ted from the dermis 
using forceps and laid on a glass microscope slide. The microsco pe 
slide was placed into the film holder of an enl arger and the pro-
j ected area of the wound was measured by planimetry. The ratio 
between the area of the wound at the time of the sacrifice (18 or 
24 h) and at the beginning of the experiment was calculated for 
the 2 wounds and used in statistical analysis (S tudent's I-test) as 
described [22]. 
RESULTS 
Kinetics of Wound Healing The kinetics of the diminution 
of the size of the wound in the absence of any treatment is pre-
sented in Fig 1. Mean values w ith confidence intervals have been 
calcul ated at different times as indicated. T his curve presents 3 
phases. A rapid covering by epidermal cells is observed during 
the first 6 h and it results in the covering of up to 30% of the 
wounded area (healing ratio 0.71 ± 0.12; the average of measures 
of20 wounds at 6 h), then during the following 18 b the covering 
is much slower and on ly 43% of the wound is covered (healing 
ratio 0.57 ± 0.1 1). T he third part of the curve corresponds to 
almost complete healing between 24-48 h (a t 48 h the healing 
ratio is 0.09 ± 0.03). . 
To analyze further the effect of growth fac tors (or dru gs) on 
the rate of wound healing, measurements were done mainly 18-24 
h after tbe beginning of the experiment since these times corre-
spond to the end of the second phase and significant differences 
could be observed (Table I) . 
Effect of Growth Factors on the Rate of Wound Healing The 
results of the healing ratios after appli ca tion of EDGF at different 
times are presented in Table I. Water and C MC gel were used as 
vehicles . A positive effect on the rate of wound healing could be 
observed using C M C gel alone as a vehicle and has previously 
been reported [23]. T his is illustrated at 24 h in 3 different ex-
periments; the measures of healing ratios were ranging between 
0.4-0.52 as opposed to 0.7 when water or nothing was added, 
although in one set of experiments we found that the healing ratio 
with water only was also 0.52 (the value of 0.7 as healing ratio 
for controls is the mean value of man y other experiments). Three 
different preparations of EDGF, the first 2 consisting of 0.1 N 
acetic-purifi ed EDGF with a SU at 400 ng/ml and the third one 
consisting of cibacrDn blue-purifi ed EDGF with a SU at 30 ng/ml 
[1 2], were used at doses corresponding to the maximal stimulation 
of in vitro ptoliferation of BEL cells. T he doses were, respec-
tively, of 5, 5, and 10 SU per appli cation. These EDGF prepa-
rations induced a marked change of the healing ratio and ap-
proximately 80% of the wound was already covered with cell s 
after 24 h (healing ra tio 0.2) 
To visualize the process of reepithelialization in our model, a 
photograph of separated epidermis 24 h after wounding is pre-
sented in Fig 2. 
Comparative studies were performed with EGF in water in 
order to avoid possible inhibitions of the biologic activity by 
CMC. Up to 1000 SU of EGF had no effect on the rate of the 
wou nd healing. T he results of this study are presented in 
Tab le ll. 
DISCUSSION 
O ur results indicate that EDGF stimulates wound healing of ep- . 
idermis in vivo, and , in agreement with our previous observation, 
that the ptoliferation of adu lt keratinocy tes could be stimulated 
Figure 2. Appearance of wounds at 24 h treated with (a) C MC gel and 
(b) EDGF in CM C gel. 
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Table II. Effect of Vehicle on W o und H ea lin g 
Contro l 
(no EGF) 
EGF 
(1000 SU llo 
Number of animals 
p' 
Average of the Heal ing Ratio· 24 
Hours after Wounding 
Vehicle 
Water C M C Gel 
0.69 ± 0.06 0.43 ± 0.08 
0.68 ± 0.06 0.52 ± 0. 11 
12 12 
NS N S 
. . surface of the wound X hours after wounding 
' Heahng ratIO = initial surface of the wound 
' Stimulation unit (SU) is defined as the amount of growth facto r added to I III I 
of culture medium wh ich can induce 50% maxima l incorporation of rJH Ith ymidine 
in target cells. O ne thousand SU correspond to 15 J-Lg (2 .5 J-L M) of pure EGF. 
'p val ues based on Student Fisher test. ± = Standard crror of the Illean (SEM); 
NS = not signi ficant 
in v itro b y EDGF [13]. Furthermore EDGF differs clea rly fro m 
EGF, not only o n bioche mica l and imm uno logic grounds [1 2], 
but also by not sti mulatin g the sa m e target cell s in vitro [9]. Our 
experiments show that this diffe ren ce does exis t in vivo as well. 
Moreover they confirm that EGF does not s timulate the prolif-
eration of human epithelial cells, as it was o bserved both afte r 
wound induction b y blis ter formation on h ealth y epidermis [6] 
and after pen etrating keratoplas ty o n the hum an eye [24], a l-
thoug h hig h doses of human EGF were recently shown to in crease 
the rate of reepithelialization of split-thickness wound in minia-
ture pigs [8]. 
More recently, evidence that EDGF cross- reacts with antibod-
ies agains t the 9 N-term.inal amino acids of FGF as well as with 
a monoclonal ant ibody against ECGF [25] has been obtained [26; 
o ur unpublished data] . Indications that retina contains ECGF-li ke 
material h as a lso been shown by another group [27]. However 
FGF h as been shown to be unable to s timula te th e growth of 
human keratinocy tes in vitro [5] w hile nondialyzcd crude prep-
arations of bovine h y pothalamus were shown to stimul ate the 
g rowth of human kera tinocytes in v itro [15] and recentl y a ke-
ratinocyte g rowth factor (KG F) w ith M, 1700 was partiall y pu-
rified [16]. 
In our study we did not undertake exp eriments to elu cidate the 
mechanism of wound healing a t the cellular level. It is unlikely 
however that cells other th an keratinocytes a re in volved sin ce the 
technique of bliste r form ation , which we used, a llows the basal 
membrane to re main intact (see Materia ls a/1d Methods). 
It is tempting to speculate that in the kin e tic curve presented 
in Fig 1 the first phase corresponds to the mig ra tion of n eig h-
boring kera tinocytes while the second and third p hases corre-
spond to cell multiplication and m aturation . C lea rl y, in order to 
confirm this hypothesis, furth er experiments sh o uld be under-
taken including the m easure of thymidine incorporation and his-
tologic s tudies analysis of the tissue as in works published b y 
other authors [21,28,29]. 
N evertheless it could b e pointed o ut that u se of the occlus ive 
dressings with polye thy lene film shortens the time necessary for 
e pidermal h ealing, prevents the formation of sca b , and, therefore, 
eases the epidermal-dermal separation, and avoids th e n eed for 
serial sections for histolog ic evaluation. 
The results presented in these experim ents indica te that EDGF 
can significantly accelerate a wound healing response at physio-
logic doses (= 5 pM). Further s tudies on other species and other 
w ound h ealing models should be undertaken . H owever prelim-
inary experiments in our laboratory h ave shown that th e best 
effect ofEDGF is obtained for the regeneration of epidermis alo ne 
and not when the d ermis also is wounded. These d ata suggest 
that an intac t b asal m embran e is needed for proper stim ulation 
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b y EDGF. The p o tential use ofEDGF as a therapeu tic agent seems 
therefo re restricted to superficial wounds or to the fin al stagc of 
healing in a deeper wound. Further in vestigatio ns, both on the 
in trinsic p h ys io logic role ofEDGF and o n its m echanism of action 
o n topica l appli ca tio n , are presentl y underway in o ur laboratory. 
Note: EDGF h as been furthe r purified and fractionated into 
EDGFI (an alagous to brai n basic FGF) and EDGFlI (ana logous 
to brain ECGF). Both purified factors can s timulate epid erm al 
wound hea lin g to the sa m e extent and a t th e sa m e d oses (10 SU). 
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